| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Mar―23 |
Multisystem inflammatory syndrome associated with COVID-19 in adult: the case report |
I.Kh. Belyaletdinova, M.A. Sayfullin, G.D. Guseva, N.E. Perekopskaya |
| 2 |
[GO] |
2023―Mar―23 |
Personalized approach to the management of a patient with COVID-19 with a complicated comorbid background |
S.A. Chepurnenko, G.V. Shavkuta, N.M. Bulgakova, A.V. Safonova |
| 3 |
[GO] |
2023―Mar―23 |
Online survey results among social network users in terms of the COVID-19 problem |
A.R. Tyapayeva, E.A. Naumova, O.N. Semenova |
| 4 |
[GO] |
2023―Mar―23 |
Impact of anti-epidemic measures on the dynamics of the incidence of COVID-19 in medical organizations with a psychoneurological profile |
M.A. Godkov, V.A. Gushchin, A.N. Tsibin, V.V. Shustov, E.A. Kasholkina |
| 5 |
[GO] |
2023―Mar―23 |
Features of inflammatory periodontal diseases course in combination with a new coronavirus disease. A systematic review |
N.R. Evarnitskaya, O.O. Yanushevich |
| 6 |
[GO] |
2023―Feb―06 |
Study of cases of Pseudomonas aeruginosa bacteria in patients with severe COVID-19 |
A.S. Malygin, M.A. Lysenko, S.V. Tsarenko, E.V. Filimonova |
| 7 |
[GO] |
2023―Feb―06 |
Olokizumab reduces the risks of death in hospitalized patients with moderate and severe COVID-19 |
E.V. Tavlueva, A.E. Markarov, M.A. Petrushin, A.A. Vizel, G.L. Ignatova, V.N. Antonov, et al. (+7) A.S. Agaf'ina, B.A. Bakirov, V.M. Mozgovaya, O.V. Filon, A.V. Zinkovskaya, A.N. Dolgorukova, M.Yu. Samsonov |
| 8 |
[GO] |
2023―Feb―06 |
Trace elements: role in the development of severe forms of COVID-19 and the possibility of correction |
A.O. Romanov, M.M. Sharipova, I.A. Popova, A.N. Arkhangelskaia, K.G. Gurevich, N.L. Shimanovskiy |
| 9 |
[GO] |
2023―Feb―06 |
Prognostic criteria for the development of severe clinical forms of COVID-19 in medical organization workers |
T.A. Platonova, T.A. Semenenko, A.A. Golubkova, E.I. Sisin, M.S. Sklyar, E.A. Karbovnichaya, S.S. Smirnova |
| 10 |
[GO] |
2023―Feb―06 |
Clinical and laboratory manifestations and pathological anatomical picture of a severe course of a new coronavirus infection COVID-19 with a fatal outcome |
R.Yu. Abdullaev, O.G. Komissarova, M.M. Rybka, E.M. Greсov, L.A. Semenova, Yu.S. Berezovsky |
| 11 |
[GO] |
2023―Feb―06 |
Approaches to vaccination against coronavirus infection in patients with autoimmune inflammatory rheumatic diseases |
A.A. Tarasova, M.P. Kostinov, M.A. Kvasova |
| 12 |
[GO] |
2023―Feb―06 |
The use of neutralizing monoclonal antibodies against SARS-CoV-2 in hemodialysis patients |
E.V. Volodina, N.F. Frolova, M.A. Lysenko, I.G. Kim, A.I. Ushakova, V.E. Vinogradov, et al. (+6) S.S. Usatiuk, A.M. Nikitina, U.A. Markina, V.I. Chervinko, E.V. Kryukov, M.L. Zubkin |
| 13 |
[GO] |
2023―Feb―06 |
Infectious mononucleosis combined with SARS-CoV-2 infection |
T.I. Kalenchic, S.L. Kabak, A.U. Rysevets |
| 14 |
[GO] |
2022―Nov―14 |
Polymorphism of genes in patients with new coronavirus infection COVID-19 |
B.I. Kantemirova, V.V. Vasilkova |
| 15 |
[GO] |
2022―Nov―14 |
Efficiency of application of sorbed probiotics in the complex therapy of pneumonia caused by SARS-CoV-2. Quality of life in the short term COVID-19 |
E.R. Meskina, M.K. Khadisova, T.V. Stashko, L.A. Galkina, E.E. Tselipanova, I.M. Shilkina |
| 16 |
[GO] |
2022―Nov―14 |
The effect of etiotropic therapy on the formation of immune disorders in patients with COVID-19 |
E.P. Tikhonova, A.A. Savchenko, T.A. Yelistratova, Yu.S. Kalinina, T.Yu. Kuz'mina, E.V. Kasparov, et al. (+3) V.D. Belenyuk, I.S. Sadovsky, A.G. Borisov |
| 17 |
[GO] |
2022―Nov―14 |
The features of the liver function tests in patients with COVID-19 |
V.K. Fazylov, A.F. Oleynik, O.F. Abdullah, V.O. Akifiev, A.М. Fayyadh, G.C. Revathy |
| 18 |
[GO] |
2022―Nov―14 |
Features of the diagnosis and course of COVID-19 in HIV-infected patients hospitalized in a hospital |
A.S. Sycheva, M.V. Nagibina, K.A. Uryanskaya, A.A. Solodov, A.L. Kebinа, I.V. Semeniakin, et al. (+2) O.V. Levchenko, O.O. Yanushevich |
| 19 |
[GO] |
2022―Nov―14 |
Features of the COVID-19 in lung tissue damage admitted to hospital |
L.V. Povalyaeva, E.S. Vdoushkina, E.A. Borodulina, E.V. Yakovleva, Zh.P. Vasneva, A.N. Gerasimov, A.E. Sukhanova |
| 20 |
[GO] |
2022―Nov―14 |
Description of the clinical picture of COVID-19 in patients with fatal outcome |
L.V. Ter-Bagdasaryan, L.I. Ratnikova, E.Yu. Lebedeva, G.V. Sychugov, A.V. Ivanova, D.V. Pirogov, et al. (+2) K.A. Nikulina, M.A. Lokteva |
| 21 |
[GO] |
2022―Nov―14 |
Vaccination against COVID-19 in patients with inflammatory bowel diseases |
A.A. Khasanova, M.P. Kostinov, I.L. Soloveva, A.P. Cherdantsev |
| 22 |
[GO] |
2022―Nov―14 |
Survey of medical university staff: assessment of COVID-19 manifestations in periods of peak and convalescence |
O.O. Yanushevich, E.N. Yushchuk, N.S. Smetneva, O.V. Levchenko, A.I. Machulina |
| 23 |
[GO] |
2022―Nov―14 |
Antibiotic therapy of Acinetobacter baumannii bloodstream infection in COVID-19 patients |
A.S. Malygin, S.V. Tsarenko, E.V. Filimonova |
| 24 |
[GO] |
2022―Nov―14 |
Clinical experience of Raphamin therapy in outpatients after hospital treatment of COVID-19 pneumonia |
A.V. Mordyk, L.V. Puzyreva, E.P. Antipova, A.V. Verbanov |
| 25 |
[GO] |
2022―Nov―14 |
A study on COVID-19 vaccine hesitancy among healthcare professionals in India |
Sree T. Sucharitha, E. Premalatha, C. Chakrapani, T.K.V. Saravanan, R. Lakshmi |
| 26 |
[GO] |
2022―Jul―28 |
Clinical and immunological parallels in children patients with COVID-19 |
O.O. Obukhova, G.S. Karpovich, T.I. Ryabichenko, G.A. Skosyreva, O.M. Gorbenko, A.N. Trunov, et al. (+2) I.V. Kuimova, M.I. Voevoda |
| 27 |
[GO] |
2022―Jul―28 |
Clinical manifestations and emotional disorders in patients with new coronavirus infection (COVID-19) |
L.I. Ratnikova, V.G. Ragozinskaya |
| 28 |
[GO] |
2022―Jul―28 |
Clinical and laboratory characteristics of new coronaviral infection (COVID-19) in children |
A.A. Khasanova, M.P. Kostinov, I.L. Soloveva, A.P. Cherdantsev |
| 29 |
[GO] |
2022―Jul―28 |
Clinical and laboratory characteristics of new coronaviral infection (COVID-19) in children |
R.T. Murzabaeva, D.A. Valishin, N.A. Abrashina, L.V. Murzagaleeva, A.D. Valishina |
| 30 |
[GO] |
2022―Jul―28 |
Evaluation of clinical outcomes of COVID-19 in patients taking remdesivir in complex therapy in routine clinical practice |
M.V. Zhuravleva, E.V. Kuznetsova, T.R. Kameneva, A.N. Kulikov, E.D. Laryushkina, O.M. Romashov, et al. (+9) S.S. Andreev, M.A. Ivzhits, E.V. Zernova, S.D. Mitrokhin, T.V. Bikbaeva, A.P. Filatova, A.V. Kryukov, A.A. Khokhlov, I.D. Abusev |
| 31 |
[GO] |
2022―Jul―28 |
Mechanisms of olfactory impairment in COVID-19: a systematic review |
A.R. Medeulova, K.A. Zhapar, D.G. Kussainova |
| 32 |
[GO] |
2022―Mar―30 |
Validation of the russian version of the 4C Mortality Score and prediction of outcomes of severe COVID-19 |
V.I. Vechorko, O.V. Averkov, N.A. Suponeva, M.A. Piradov, A.A. Zimin, Ja.G. Yusupova, et al. (+8) A.B. Zaitsev, D.V. Grishin, N.V. Polekhina, A.V. Naminov, N.M. Ramchandani, S.R. Knight, M.G. Semple, E.M. Harrison |
| 33 |
[GO] |
2022―Mar―30 |
Prevention of COVID-19 coronavirus infection with aminodihydrophthalazinedione sodium (Galavit®) in medical staff of the “red zone”: results of the multicenter observational study |
S.V. Kolesov, M.E. Mozheyko, G.S. Trufanov, D.S. Gorbatyuk |
| 34 |
[GO] |
2022―Mar―30 |
Some clinical and epidemiological aspects of the course of COVID-19 in people living with HIV |
N.N. Dolgova, A.A. Ryndich, A.G. Suladze, T.I. Tverdokhlebova, A.N. Matuzkova, K.Kh. Bolatchiev, L.F. Chernigovec |
| 35 |
[GO] |
2022―Mar―30 |
Listeriosis and the COVID-19 pandemic |
E.А. Klimova, O.L. Voronina, G.N. Karetkina, E.A. Posukhovsky, N.N. Ryzhova, M.S. Kunda, et al. (+12) E.I. Aksenova, A.V. Kutuzova, T.I. Karpova, I.S. Tartakovskiy, A.Yu. Pokidysheva, T.V. Pronina, A.R. Melkumyan, O.E. Orlova, E.N. Burmistrova, A.A. Syrochev, S.V. Smetanina, N.D. Yushchuk |
| 36 |
[GO] |
2022―Mar―30 |
Preliminary analysis of the epidemiological effectiveness of COVID-19 vaccination in the Saratov Region |
A.N. Danilov, T.L. Abramyan, I.A. Mamonova, I.E. Irishkova, D.A. Teisherskaya |
| 37 |
[GO] |
2022―Mar―30 |
COVID-19: the efficacy and safety of anticoagulant, glucocorticosteroid therapy and metabolic |
D.P. Salivonchyk, I.О. Stoma, E.A. Dotsenko, N.N. Kudenchuk, E.I. Salivonchyk, I.A. Khudyakov, et al. (+7) M.N. Menshakova, E.I. Malashchenko, S.D. Salivonchyk, K.O. Bondareva, E.A. Stepanets, O.V. Konovalova, E.V. Kuhoreva |
| 38 |
[GO] |
2022―Mar―30 |
Determination of antibodies to SARS-CoV-2 in patients with coronavirus infection |
G.M. Ignatyev, L.I. Kozlovskaya, K.M. Mefed, V.P. Volok, I.Kh. Belyaletdinova, A.A. Erovichenkov, et al. (+8) D.M. Danilenko, N.L. Aleshenko, S.A. Klotchenko, N.L. Maksimov, E.K. Atremov, A.N. Piniaeva, D.A. Lioznov, A.A. Ishmukhametov |
| 39 |
[GO] |
2022―Mar―30 |
Features of the course and medical and social aspects of a new coronavirus infection in the Republic of Tajikistan |
Ja.A. Abdullozoda, J.Yu. Salomudin, R.A. Tursunov |
| 40 |
[GO] |
2022―Mar―30 |
Results of screening examination of employees of a medical hospital for antibodies to SARS-CoV-2 |
R.F. Sayfullin, S.K. Pylaeva, D.O. Sinyavkin |
| 41 |
[GO] |
2021―Dec―23 |
The use of enterosorbents in the immunorehabilitation of patients who have had a new coronavirus infection COVID-19 |
E.P. Tikhonova, A.A. Savchenko, T.Yu. Kuz'mina, Yu.S. Kalinina, N.A. Dyachenko, A.A. Masterova, et al. (+3) V.D. Belenyuk, A.G. Borisov, M.A. Popilov |
| 42 |
[GO] |
2021―Dec―23 |
The therapeutics, based on virus specific antibodies, for special prophylactic and current of COVID-19 |
T.E. Sizikova, E.V. Lebedinskaya, V.N. Lebedev, S.V. Borisevich |
| 43 |
[GO] |
2021―Dec―23 |
Markers of acute inflammation in patients with COVID-19 in combination with hypertension |
V.V. Kiseleva, K.S. Yachmenev, L.Yu. Zaitseva |
| 44 |
[GO] |
2021―Dec―23 |
Overview of the "Partnership against the pandemic session: anti-crisis strategies in medicine" within the framework of the Eastern Economic Forum "New opportunities of the Far East in a changing world" |
G.E. Ulumbekova |
| 45 |
[GO] |
2021―Oct―04 |
Analysis of deaths during the first wave of a new coronavirus infection - COVID-19 |
R.A. Tursunov, D.A. Olimov, G.M. Khojamuradov |
| 46 |
[GO] |
2021―Oct―04 |
Analysis data of mechanism of drugs recommended for the treatment of COVID-19 |
O.A. Radaeva, Yu.A. Kostina |
| 47 |
[GO] |
2021―Oct―04 |
Antibiotic resistance of Klebsiella pneumoniae against the background of the COVID-19 pandemic: experience of the multidisciplinary hospital |
D.V. Tapalski, E.V. Karpova, O.M. Akulenok, V.K. Okulich, I.I. Generalov, N.Yu. Leskova, et al. (+5) E.G. Antonova, I.V. Zhiltsov, O.V. Osipkina, L.V. Mozharovskaya, O.Yu. Baranov |
| 48 |
[GO] |
2021―Oct―04 |
Economic aspects of COVID-19 treatment in a hospital setting |
E.A. Zhidkova, R.I. Shaburov, S.V. Cheremushkin, A.V. Gubkin, I.V. Rogova, I.A. Popova, K.G. Gurevich |
| 49 |
[GO] |
2021―Oct―04 |
Analysis of clinical cases of new coronavirus infection in patients with a history of heart transplantation |
V.V. Kiseleva, N.S. Kolupaev, Yu.A. Rogova |
| 50 |
[GO] |
2021―Oct―04 |
Frequency of SARS-CoV-2 infection in hemodialysis patients |
M.L. Zubkin, V.Yu. Shilo, L.I. Novikova, O.Yu. Borisova, I.G. Kim, S.S. Bochkareva, et al. (+7) L.A. Dragina, O.B. Rybakova, N.V. Gudova, E.V. Volodina, V.I. Chervinko, N.A. Tomilina, E.V. Kryukov |
| 51 |
[GO] |
2021―Jul―02 |
Morphofunctional changes in the conducting and respiratory parts of the bronchopulmonary system in COVID-19 (analytical review) |
V.I. Kobylyansky |
| 52 |
[GO] |
2021―Jul―02 |
Differentiated approach to the implementation of preventive and anti-epidemic measures among military personnel based on the COVID-19 disease risk assessment scale |
E.V. Kryukov, D.V. Cherkashin, I.A. Reutskiy, V.N. Solntsev, S.A. Bucenko, A.D. Sobolev, et al. (+4) B.V. Levankov, M.V. Dmitriev, S.V. Efimov, G.G. Kutelev |
| 53 |
[GO] |
2021―Jul―02 |
Retrospective analysis of risk factors for COVID-19 in the working population |
E.A. Zhidkova, E.M. Gutor, Yu.А. Tkachenko, I.V. Rogova, I.A. Popova, K.G. Gurevich |
| 54 |
[GO] |
2021―Mar―30 |
COVID-19 in hemodialysis patients |
N.F. Frolova, I.G. Kim, A.I. Ushakova, S.S. Usatiuk, L.Yu. Artyukhina, R.T. Iskhakov, et al. (+9) V.V. Varyasin, D.O. Sinyavkin, E.N. Diakova, K.E. Loss, V.I. Chervinko, E.V. Volodina, N.A. Tomilina, E.V. Kryukov, M.L. Zubkin |
| 55 |
[GO] |
2021―Feb―01 |
Efficacy and safety of favipiravir in a complex therapy of mild to moderate COVID-19 |
Tatiana A. Ruzhentsova, Pavel V. Chukhlyaev, Daria A. Khavkina, Alexander A. Garbuzov, Antonina A. Ploskireva, Rodion A. Oseshnyuk, et al. (+26) Tatyana N. Soluyanova, Irina V. Shestakova, Adel Yu. Vafin, Elena P. Dmitrikova, Dzhavanshir M. Mustafaev, Tatiana N. Domostroeva, Maria V. Otpushchennikova, Konstantin A. Pokrovskiy, Marina G. Rusanova, Dmitriy A. Bistritskiy, Тatyana N. Markova, Elena A. Kaplun, Diana V. Petina, Nataliya E. Kostina, Viсtoria S. Lesina, Sergey G. Shcherbak, Alina S. Agaf'ina, Yury F. Brook, Oleg Yu. Bronov, Evgeny I. Shults, Emilia N. Krasavina, Mikhail Yu. Samsonov, Arkadiy V. Zintchenko, Mariya V. Nikolskaya, Viсtoria A. Razzhivina, Olga V. Filon |
| 56 |
[GO] |
2021―Feb―01 |
Features of the steroid profile of saliva in patients with COVID-19 |
Svetlana Yu. Kalinchenko, Sergey Yu. Ivanov, Leonid L. Borozdkin, Roman A. Terushkin, Andrei A. Isaev, Artur R. Avetisyan, Aslan R. Shurmudov |
| 57 |
[GO] |
2021―Feb―01 |
Novel coronavirus disease (COVID-19) and cytokine storms. For more effective treatments from the viewpoints of an inflammatory pathophysiology perspective |
Shumpei Yokota, Yoshiyuki Kuroiwa, Kusuki Nishioka |
| 58 |
[GO] |
2021―Feb―01 |
Surgical care for adults on "urology" in the context of the COVID-19 pandemic |
Alexander O. Vasilyev, Vigen A. Malkhasyan, Gevorg R. Kasyan, Alexander V. Govorov, Lyubov A. Khodyreva, Konstantin B. Kolontarev, et al. (+2) Arseniy A. Shiryaev, Dmitry Y. Pushkar |
| 59 |
[GO] |
2020―Oct―08 |
New possibilities for targeted antiviral therapy for COVID-19. Results of a multi center clinical study of the efficacy and safety of using the drug Areplivir |
L.A. Balykova, M.V. Granovskaya, K.Y. Zaslavskaya, E.N. Simakina, A.S. Agaf'ina, A.Y. Ivanova, et al. (+2) K.B. Kolontarev, D.Y. Pushkar |
| 60 |
[GO] |
2020―Oct―08 |
Experience of the infectious service of the Republic of Saкha (Yakutia) during the pandemic of the new coronavirus infection |
S.S. Sleptsovа, E.A. Borisova, V.E. Tarasova, E.Yu. Malinnikova |
| 61 |
[GO] |
2020―Oct―08 |
Could influenza vaccination be a non-specific prevention of SARS-CoV-2 and other respiratory infections? |
M.P. Kostinov, E.A. Khromova, A.M. Kostinova |
| 62 |
[GO] |
2020―Jul―09 |
Modern representations of the new coronavirus and the disease caused by SARS-COV-2 |
M.P. Kostinov, A.D. Shmitko, V.B. Polishchuk, E.A. Khromova |
| 63 |
[GO] |
2020―Jul―09 |
The hypothesis of epidemic welfare for SARS-CoV-2 in Russia |
M.P. Kostinov |
| 64 |
[GO] |
2020―Jul―09 |
New coronaviral infection. Today’s look at the pandemic of the XXI century |
E.Yu. Malinnikova |
